PB2196: EQUATOR: A PIVOTAL PHASE 3 DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED STUDY OF ITOLIZUMAB IN COMBINATION WITH CORTICOSTEROIDS FOR THE INITIAL TREATMENT OF ACUTE GRAFT-VERSUS-HOST DISEASE
J. Koreth,
L. Kean,
L. Chinn,
L. M. Acevedo,
O. Bandman,
J. Rothman,
S. Connelly,
D. Thomas,
C. Cutler
Affiliations
J. Koreth
1 Division of Stem Cell Transplantation and Cellular Therapy
L. Kean
2 Department of Pediatric Oncology, Dana Farber Cancer Institute and Harvard Medical School, Boston
L. Chinn
3 Equillium, Inc., La Jolla, United States of America
L. M. Acevedo
3 Equillium, Inc., La Jolla, United States of America
O. Bandman
3 Equillium, Inc., La Jolla, United States of America
J. Rothman
3 Equillium, Inc., La Jolla, United States of America
S. Connelly
3 Equillium, Inc., La Jolla, United States of America
D. Thomas
3 Equillium, Inc., La Jolla, United States of America
C. Cutler
1 Division of Stem Cell Transplantation and Cellular Therapy
